La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
D B Calne29
Canada Sauf D B Calne" 7482
D B Calne Sauf Canada" 3
Canada Et D B Calne 26
Canada Ou D B Calne 7511
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 26.
Ident.Authors (with country if any)Title
002D81 J. Carr [Canada] ; R. De La Fuente-Fernández ; M. Schulzer ; E. Mak ; S M Calne ; D B CalneFamilial and sporadic Parkinson's disease usually display the same clinical features.
002E80 G V Mcdonnell [Canada] ; J. Cabrera-Gomez [Canada] ; D B Calne [Canada] ; D Kb Li [Canada] ; J. Oger [Canada]Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions
002F61 S. Furtado [Canada] ; M. Farrer ; Y. Tsuboi ; M L Klimek ; R. De La Fuente-Fernández ; J. Hussey ; P. Lockhart ; D B Calne ; O. Suchowersky ; A J Stoessl ; Z K WszolekSCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
003476 P K Pal [Canada] ; A. Samii [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; I M Turnbull [Canada] ; D B Calne [Canada]Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years
003622 D B Calne [Canada]Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
003A68 H. Shinotoh [Canada] ; F J Vingerhoets ; C S Lee ; R J Uitti ; M. Schulzer ; D B Calne ; J. TsuiLamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
003A70 H. Shinotoh [Canada] ; B. Thiessen ; B J Snow ; S. Hashimoto ; P. Macleod ; I. Silveira ; G A Rouleau ; M. Schulzer ; D B CalneFluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
003A73 D B Calne [Canada] ; R. De La Fuente-Fernández ; A. KishoreContributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
003C84 A. Kishore [Canada] ; Z K Wszolek ; B J Snow ; R. De La Fuente-Fernandez ; F. Arwert ; M. Wijker ; M. Schulzer ; D B Calne ; F J VingerhoetsPresynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.
003F15 H. Shinotoh [Canada] ; B J Snow ; K A Hewitt ; B D Pate ; D. Doudet ; R. Nugent ; D P Perl ; W. Olanow ; D B CalneMRI and PET studies of manganese-intoxicated monkeys.
004118 D B Calne [Canada]Initiating treatment for idiopathic parkinsonism.
004125 D B Calne [Canada]Early idiopathic parkinsonism: initiation and optimization of treatment.
004466 M. Cordes [Canada] ; B J Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D B Calne[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
004467 D B Calne [Canada] ; F H Hochberg ; B J Snow ; T. NygaardTheories of neurodegeneration.
004673 M H Bhatt [Canada] ; S P Keenan ; J A Fleetham ; D B CalnePleuropulmonary disease associated with dopamine agonist therapy.
004840 K C Petruk [Canada] ; A F Wilson ; D R Schindel ; N J Witt ; D R Mclean ; P A Mcfarland ; R G Johnston ; M S Mcphee ; W R Martin ; D B CalneTreatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgery.
004846 R F Peppard [Canada] ; C S Lu ; N S Chu ; P. Teal ; W R Martin ; D B CalneParkinsonism with neuroacanthocytosis.
004847 D B Calne [Canada] ; A. EisenParkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
004858 J K Tsui [Canada] ; R F Peppard ; K C Petruk ; G. Allen ; R S Burns ; D B CalneDecreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants.
004A07 D B Calne [Canada] ; A. EisenThe relationship between Alzheimer's disease, Parkinson's disease and motor neuron disease.
004A12 H. Ter V Inen [Canada] ; J K Tsui ; E. Mak ; D B CalneOptimal indices for testing parkinsonian rigidity.
004A21 D B Calne [Canada]Current concepts on the etiology of Parkinson's disease.
004B00 D B Calne [Canada]Is "Parkinson's disease" one disease?
004B47 W R Martin [Canada] ; A J Stoessl ; M. Palmer ; M J Adam ; T J Ruth ; J R Grierson ; B D Pate ; D B CalnePET scanning in dystonia.
005613 D B Calne [Canada]Parkinson's disease over the last 20 years: a personal view.
005624 P K Pal [Canada] ; A. Samii ; D B CalneManganese neurotoxicity: a review of clinical features, imaging and pathology.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022